Last news
Founder Group Secures Multiple Contracts Worth Approximately US$5.5 Million

Founder Group Secures Multiple Contracts Worth Approximately US$5.5 Million

...

Fortinet to Host Analyst Day on its 15-Year IPO Anniversary

Fortinet to Host Analyst Day on its 15-Year IPO Anniversary

...

OPEN Health Presents First Collection of Research Backed by Scientific Buyout Fund to Foster Research and Development

OPEN Health Presents First Collection of Research Backed by Scientific Buyout Fund to Foster Research and Development

...

EBC Financial Group Registers Trademark in Chile, Strengthening Its Latin American Footprint

EBC Financial Group Registers Trademark in Chile, Strengthening Its Latin American Footprint

...

Monsha’at: Biban24 fuels regional SME growth and development with landmark agreements worth over SAR 35 billion launched during exhibition

Monsha’at: Biban24 fuels regional SME growth and development with landmark agreements worth over SAR 35 billion launched during exhibition

...

Monsha’at: Biban 2024 accelerates transformation of Saudi entrepreneurship with over SAR 10.6 billion worth of agreements

Monsha’at: Biban 2024 accelerates transformation of Saudi entrepreneurship with over SAR 10.6 billion worth of agreements

...

Teva to Present at the Jefferies London Healthcare Conference

Teva to Present at the Jefferies London Healthcare Conference

...

Io Therapeutics, Inc., announces presentation of data on its RAR gamma agonist compound IRX5010 demonstrating inhibition of tumor infiltrating myeloid derived suppressor cells, promotion of tumor infiltrating T-cells, and effective tumor growth inhibition

Io Therapeutics, Inc., announces presentation of data on its RAR gamma agonist compound IRX5010 demonstrating inhibition of tumor infiltrating myeloid derived suppressor cells, promotion of tumor infiltrating T-cells, and effective tumor growth inhibition

Notified -...

1 ... 371 372 373 374 375 376 377 378 379 ... 1035
menu
menu